Alzheimer's disease

Major milestone in fight against Alzheimer’s disease

Eisai Co. and partner Biogen Inc. said their drug significantly slowed Alzheimer’s disease, making it the first medicine to blunt progression of the most common dementia in a definitive, large-scale trial.